FR2623400B1 - Facteur d'activation des neutrophiles - Google Patents

Facteur d'activation des neutrophiles

Info

Publication number
FR2623400B1
FR2623400B1 FR8815025A FR8815025A FR2623400B1 FR 2623400 B1 FR2623400 B1 FR 2623400B1 FR 8815025 A FR8815025 A FR 8815025A FR 8815025 A FR8815025 A FR 8815025A FR 2623400 B1 FR2623400 B1 FR 2623400B1
Authority
FR
France
Prior art keywords
activation factor
neutrophilic activation
neutrophilic
factor
activation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR8815025A
Other languages
English (en)
Other versions
FR2623400A1 (fr
Inventor
Heinrich Aschauer
Ivan James Dalton Lindley
Paola Peveri
Alfred Walz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kocher Theodor Institut
Sandoz AG
Original Assignee
Kocher Theodor Institut
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27263673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR2623400(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB878727053A external-priority patent/GB8727053D0/en
Priority claimed from GB888805070A external-priority patent/GB8805070D0/en
Priority claimed from GB888825258A external-priority patent/GB8825258D0/en
Application filed by Kocher Theodor Institut, Sandoz AG filed Critical Kocher Theodor Institut
Publication of FR2623400A1 publication Critical patent/FR2623400A1/fr
Application granted granted Critical
Publication of FR2623400B1 publication Critical patent/FR2623400B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR8815025A 1987-11-19 1988-11-18 Facteur d'activation des neutrophiles Expired - Lifetime FR2623400B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878727053A GB8727053D0 (en) 1987-11-19 1987-11-19 Neutrophil-activating factor(naf)
GB888805070A GB8805070D0 (en) 1988-03-03 1988-03-03 Neutrophil-activating factor(naf)
GB888825258A GB8825258D0 (en) 1988-10-28 1988-10-28 Neutrophil-activating factor

Publications (2)

Publication Number Publication Date
FR2623400A1 FR2623400A1 (fr) 1989-05-26
FR2623400B1 true FR2623400B1 (fr) 1995-06-23

Family

ID=27263673

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8815025A Expired - Lifetime FR2623400B1 (fr) 1987-11-19 1988-11-18 Facteur d'activation des neutrophiles

Country Status (23)

Country Link
US (1) US6383479B1 (fr)
JP (1) JP3133305B2 (fr)
KR (1) KR890701625A (fr)
AT (1) ATA901588A (fr)
AU (1) AU622125B2 (fr)
BE (1) BE1001817A5 (fr)
CH (1) CH680001A5 (fr)
DE (2) DE3890998T1 (fr)
DK (1) DK354389A (fr)
ES (1) ES2014546A6 (fr)
FI (1) FI893474A (fr)
FR (1) FR2623400B1 (fr)
GB (1) GB2223225B (fr)
GR (1) GR880100775A (fr)
HU (1) HU205617B (fr)
IL (1) IL88404A0 (fr)
IT (1) IT1224574B (fr)
NL (1) NL194982C (fr)
NZ (1) NZ226990A (fr)
PL (1) PL275881A1 (fr)
PT (1) PT89026B (fr)
SE (1) SE8902507L (fr)
WO (1) WO1989004836A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5652338A (en) * 1988-03-16 1997-07-29 The United States Of America As Represented By The Department Of Health And Human Services Neutrophil chemotactic factor
WO1990000563A1 (fr) * 1988-07-07 1990-01-25 United States Government, As Represented By The Department Of Health & Human Services Methode de traitement des maladies dues a des etats immunodeficients par l'adminsitration a l'homme d'un facteur chimiotactique neutrophile humain
EP0429542B1 (fr) * 1988-08-15 1995-12-06 Brigham And Women's Hospital Inhibiteur d'adhesion de leucocytes
DE68919085T2 (de) * 1988-08-29 1995-04-06 Dainippon Pharmaceutical Co Verfahren zur herstellung eines polypeptids welches als menschlicher neutrophiler chemotaktischer faktor aktiv ist.
JP2844260B2 (ja) * 1988-11-10 1999-01-06 ステファン チャールズ マックケイブ シャワーヘッド組立体
US5241049A (en) * 1989-12-22 1993-08-31 Zymogenetics, Inc. Neutrophil chemoattractants
US5079228A (en) * 1990-02-05 1992-01-07 Board Of Regents, The University Of Texas System Peptide inhibitors of neutrophil activating factor induced chemotaxis
IE913192A1 (en) * 1990-09-12 1992-02-25 Scripps Research Inst Active site of interleukin-8: polypeptide analogs and¹antibodies
WO1993001826A1 (fr) * 1991-07-19 1993-02-04 East Carolina University Methode de traitement de l'asthme
US5401651A (en) * 1991-10-16 1995-03-28 Walz; Alfred DNA encoding ENA-78, a neutrophil activating factor
GB9124775D0 (en) * 1991-11-21 1992-01-15 Medical Res Council Cervical ripening
CA2124461A1 (fr) * 1991-12-04 1993-06-10 Ian Clark-Lewis Analogues de l'interleukine-8 humaine
GB9807721D0 (en) * 1998-04-08 1998-06-10 Chiron Spa Antigen
CN114391095A (zh) * 2019-06-27 2022-04-22 比纳瑞有限责任公司 适用于即时(poc)诊断测试绝对嗜中性粒细胞功能(anf)的即时(poc)测量的全血和体液中吞噬性白细胞的基于氧化酶的化学发光测定

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5652338A (en) * 1988-03-16 1997-07-29 The United States Of America As Represented By The Department Of Health And Human Services Neutrophil chemotactic factor
JPH03505037A (ja) 1988-05-02 1991-11-07 大日本製薬株式会社 ヒト好中球走化因子ポリペプチドの製造方法
EP0429542B1 (fr) 1988-08-15 1995-12-06 Brigham And Women's Hospital Inhibiteur d'adhesion de leucocytes
AU4665689A (en) * 1989-12-11 1991-07-18 Wallac Oy Elastic scintillator material

Also Published As

Publication number Publication date
SE8902507D0 (sv) 1989-07-11
HU886790D0 (en) 1990-01-28
PT89026A (pt) 1988-12-01
HU205617B (en) 1992-05-28
DK354389D0 (da) 1989-07-18
IT1224574B (it) 1990-10-04
NL194982C (nl) 2003-04-10
ATA901588A (de) 1994-07-15
BE1001817A5 (fr) 1990-03-13
IT8848572A0 (it) 1988-11-18
CH680001A5 (fr) 1992-05-29
WO1989004836A1 (fr) 1989-06-01
AU622125B2 (en) 1992-04-02
DE3890998T1 (de) 1991-02-21
FR2623400A1 (fr) 1989-05-26
GB8913271D0 (en) 1989-12-06
GB2223225A (en) 1990-04-04
NL8820928A (nl) 1989-10-02
DK354389A (da) 1989-09-19
KR890701625A (ko) 1989-12-21
SE8902507L (sv) 1989-07-11
GR880100775A (el) 1994-03-31
ES2014546A6 (es) 1990-07-16
US6383479B1 (en) 2002-05-07
AU2716288A (en) 1989-06-14
IL88404A0 (en) 1989-06-30
HUT52551A (en) 1990-07-28
DE3890998B4 (de) 2008-01-03
JPH02502825A (ja) 1990-09-06
PL275881A1 (en) 1989-07-24
GB2223225B (en) 1992-07-08
JP3133305B2 (ja) 2001-02-05
PT89026B (pt) 1993-02-26
FI893474A0 (fi) 1989-07-18
FI893474A (fi) 1989-07-18
NZ226990A (en) 1991-10-25

Similar Documents

Publication Publication Date Title
DK686187D0 (da) Veterinaert praeparat
FR2617565B1 (fr) Electrovalve
FR2640142B1 (fr) Peptide-2 d'activation des neutrophiles
LV10019A (lv) Herbicida sastavs
DK477588D0 (da) Arylendiaminosubstituerede triaziner
FR2623400B1 (fr) Facteur d'activation des neutrophiles
DK444288D0 (da) Humant reg - protein
DK482488D0 (da) 3'-demethoxyepipodophyllotoxinglucosidderivater
DK571488A (da) Polyesterpraeparat
AT399416B (de) Elektromagnet
DK662587A (da) Herbicidt praeparat
KR890013578U (ko) 연결부재
IT1226635B (it) Sedia
KR890000227U (ko) 간이 의자
KR880015566U (ko) 낚 시
BR8706415A (pt) Multiplexador-mdt 64
SE8703558D0 (sv) "varmslaktemballering"
SE8704273D0 (sv) "kaffepasen"
SE8700965D0 (sv) "varmslaktemballering"
KR880016818U (ko) 솔레노이드
KR890002075U (ko) 안락 의자
BR6701435U (pt) Poltrona
DK477487D0 (da) Praeparat
SE8701659D0 (sv) Destillationsapparat
BR8703455A (pt) Assento

Legal Events

Date Code Title Description
TP Transmission of property